logo

GC corporation

107 Ihyeon-ro 30-beongil, Giheung-gu, Yongin-si, Gyeonggi-do


Update Date : 2024-12-22
Company information
Related News

  • GC Corp (GC) is a biopharmaceutical company producing blood products, prescription drugs, vaccines, quasi-drugs, medical instruments, sanitary products, food additives, nutritional injections, placenta injections, and cell therapy products. In FY2023, the company reported revenues of $2.0 bil a 1% decrease from FY2022.
  • Third-Generation Recombinant Factor VIII Treatment for Hemophilia Plasma Derivatives Vaccines
  • Public
  • Pharma, Medical device, CDMO, Bio
  • Code
    Phase I
    Idursulfase-beta
    Hunter syndrome
    Code
    Phase I
    Undisclosed
    Hemophilia A, B
    Code
    Registration
    Undisclosed
    Anthrax vaccine
    Code
    Phase III
    IVIG-SN
    Pediatric Immuno Deficiency
    Code
    Phase III
    Undisclosed
    Tuberculosis vaccine
    Code
    Phase I
    Undisclosed
    Treatment of Sanfilippo Syndrome Type A
Copyright ⓒ BQURA, Mediandshare 2024

Publisher-Editor : Wan Ju (Jay) Kim

Address : 919, 33, International Finance Road 6-gil, Yeongdeungpo-gu, Seoul, Korea

Tel : 82-10-9336-6304 / [email protected]

Copyright ⓒ BQURA, Mediandshare 2024

BQURA